Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CRP is additive and independent of apo B/A1 ratio in explaining the clinical benefits of atorvastatin 80mg in ACS patients in PROVE IT-TIMI 22

CRP is additive and independent of apo B/A1 ratio in explaining the clinical benefits of atorvastatin 80mg in ACS patients in PROVE IT-TIMI 22. Circulation. 2005; 112(17):II-483-4.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.